95498 ⎘
Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings Peri-condensed systems
OXAZEPINE COMPOUNDS COMPRISING A 6-AZA MOIETY AND USES THEREOF
#2SUBSTITUTED HETEROAROMATIC AMINES AND USES THEREOF
#3HETEROCYCLIC COMPOUNDS AS NRAS INHIBITORS
#4NITROGEN CONTAINING CONDENSED 2,3-DIHYDROQUINAZOLINONE COMPOUNDS AS NAV1.8 INHIBITORS
#5TRICYCLIC DERIVATIVES AND RELATED USES
#6SOLID FORMS OF A MACROCYCLIC COMPOUNDS AS CFTR MODULATORS AND THEIR PREPARATION
#7HETEROCYCLIC COMPOUND, LIGHT-EMITTING DEVICE INCLUDING HETEROCYCLIC COMPOUND, AND APPARATUS INCLUDING LIGHT-EMITTING DEVICE
#8KINASE INHIBITORS, PREPARATION METHODS AND USES THEREOF
#9KINASE INHIBITORS, PREPARATION METHODS AND USES THEREOF
#10MACROCYCLIC AZOLOPYRIDINE DERIVATIVES AS EED AND PRC2 MODULATORS
#11Pyrimidine Heterocyclic Compound, Preparation Method Thereof and use Thereof in Medicine
#12INHIBITORS OF MUTANT IDH1 AND IDH2
#13METHODS FOR THE ACYLATION OF MAYTANSINOL
#14FOUR-MEMBERED FUSED RING COMPOUND AND PREPARATION METHOD AND USE THEREOF
#15MACROCYCLIC COMPOUNDS AND USES THEREOF
#16AZACARBENE CARBON FREE RADICAL MOLECULES, MIXTURES AND FORMULATIONS COMPRISING SAME, AND USES THEREOF IN ORGANIC ELECTRONIC DEVICES
#17HETEROCYCLIC COMPOUNDS AND METHODS OF USE THEREOF
#18A SERIES OF PYRROLE DERIVATIVES AND THEIR PREPARATION METHOD AND THERAPEUTIC USE
#19METHODS FOR THE ACYLATION OF MAYTANSINOL
#20A CLASS OF FUSED RING COMPOUNDS, AND PREPARATION AND USE THEREOF
#21SMALL MOLECULE INHIBITORS OF KRAS G12C MUTANT
#22MACROCYCLIC LRRK2 KINASE INHIBITORS
#23ACYCLIC OXAZEPINE COMPOUNDS COMPRISING A 6-AZA MOIETY AND USES THEREOF
#24Fused Ring Derivatives Useful as KRAS G12D Inhibitors
#25METHODS FOR THE ACYLATION OF MAYTANSINOL
#26Macrocyclic azolopyridine derivatives as EED and PRC2 modulators
#27ORGANIC COMPOUND, OPTOELECTRONIC DEVICE INCLUDING THE SAME, AND ELECTRONIC APPARATUS INCLUDING THE OPTOELECTRONIC DEVICE
#28MACROCYCLIC COMPOUND, PHARMACEUTICAL COMPOSITION, AND USE THEREOF
#29HETEROCYCLIC COMPOUNDS AND METHODS OF USE THEREOF
#30VOLUMETRIC LED ALIGNMENT AID FOR SIGHTING DEVICE
#31MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES
#32MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES
#33PREPARATION AND APPLICATION OF TRICYCLIC PYRIMIDINONE COMPOUND AND ITS COMPOSITION
#34CONDENSED CYCLIC COMPOUND, LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE
#35ORGANIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT
#36PRC1 INHIBITORS AND METHODS OF TREATMENT THEREWITH
#37CYCLIC COMPOUNDS AND METHODS OF USING SAME
#38COVALENT RAS INHIBITORS AND USES THEREOF
#39Macrocyclic compounds and uses thereof
#40TETRACYCLIC COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF
#41Macrocyclic Compounds as Sting Agonists and Methods and Uses Thereof
#42METHODS OF PREPARING MACROCYCLIC INDOLES
#43RAPAMYCIN ANALOGS AND USES THEREOF
#44MACROCYCLIC MCL-1 INHIBITORS AND METHODS OF USE
#45OXAAZAQUINAZOLINE-7(8H)-KETONE COMPOUND, PREPARATION METHOD THEREFOR AND PHARMACEUTICAL APPLICATION THEREOF
#46OXYGEN LINKED PYRIMIDINE DERIVATIVES
#47Macrocyclic azolopyridine derivatives as EED and PRC2 modulators
#48MACROCYCLIC COMPOUNDS AS STING AGONISTS
#49Tricyclic pyridones and pyrimidones
#50Macrocyclic compound and use thereof
#51Near-infrared nerve-sparing fluorophores
#52MACROCYCLIC MCL-1 INHIBITORS AND METHODS OF USE
#532-AMINO-QUINOLINE DERIVATIVES
#542-amino-quinoline derivatives
#55Macrocyclic compounds and uses thereof
#56Tricyclic heterocycles as BET protein inhibitors
#57Serine/threonine kinase inhibitors
#58Tetracyclic heterocycle compounds useful as HIV integrase inhibitors
#59Macrocyclic azolopyridine derivatives as EED and PRC2 modulators
#60MACROCYCLIC MCL-1 INHIBITORS AND METHODS OF USE
#61Compounds for electronic devices
#62Macrocyclic compounds and uses thereof
#63Methods for the acylation of maytansinol
#64Tricyclic heterocycles as BET protein inhibitors
#65Topoisomerase inhibitors with antibacterial and anticancer activity
#66Macrocyclic indole derivatives
#67Serine/threonine kinase inhibitors
#68Oxygen linked pyrimidine derivatives
#692-amino-quinoline derivatives
#70PRC1 inhibitors and methods of treatment therewith
#71Tricyclic heterocycle compounds useful as HIV integrase inhibitors
#72Inhibitors of hepatitis C virus
#73Macrocyclic purines for the treatment of viral infections
#74Tetracyclic heterocycle compounds useful as HIV integrase inhibitors
#75Analogs of yohimbine and uses thereof
#76Serine/threonine kinase inhibitors
#77Methods for the acylation of maytansinol
#78Method for the synthesis of rapamycin derivatives
#79Inhibitors of hepatitis C virus
#80Tricyclic heterocycles as BET protein inhibitors
#81Imidazopyridine macrocycles as inhibitors of human immunodeficiency virus replication
#82Macrocyclic ghrelin receptor modulators and methods of using the same
#83Tetracyclic heterocycle compounds useful as HIV integrase inhibitors
#84Solid-state image sensor, photoelectric conversion film, electron blocking layer, imaging apparatus, and electronic device
#85Organic electroluminescent materials and devices
#86CYTOTOXIC AGENTS COMPRISING NEW MAYTANSINOIDS (DM4)
#87Serine/threonine kinase inhibitors
#88Crystalline forms of an antiviral compound
#89Inhibitors of HIF prolyl hydroxylase
#90Tricyclic heterocycles as BET protein inhibitors
#91Pyridazinone macrocycles as IRAK inhibitors and uses thereof
#92Organic electroluminescent materials and devices
#93Antibacterial compounds
#94Process for the synthesis of 2-(2,5-dimethyl-1H-pyrrol-1-yl)-1,3-propanediol and its substituted derivatives
#95Compounds for treatment of fluoroquinolone-resistant bacteria
#96Pyrazolopyrimidine macrocycles as inhibitors of human immunodeficiency virus replication
#97Macrocyclic ghrelin receptor modulators and methods of using the same
#98Organic electroluminescent materials and devices
#99Pyrazolopyrimidine macrocycles as inhibitors of human immunodeficiency virus replication
#100Inhibitors of hepatitis C virus
#101Forms of rifaximin and uses thereof
#102Polycyclic-carbamoylpyridone compounds and their pharmaceutical use
#103IAP binding compounds
#104Methods and intermediates for preparing macrolactams
#105Pyridazinone macrocycles as IRAK inhibitors and uses thereof
#106Fused tricyclic heterocyclic compounds as HIV integrase inhibitors
#107Organic electroluminescent materials and devices
#108Tricyclic triazolic compounds
#109Tricyclic heterocycles as BET protein inhibitors
#110Inhibitors of human immunodeficiency virus replication
#111Substituted benzo[5,6]azepino[3,2,1-hi]pyrido[4,3-b]indoles and substituted benzo[6,7][1,4]oxazepino[2,3,4-hi]pyrido[4,3-b]indoles for treating CNS disorders
#112MACROCYCLIC RIP2 KINASE INHIBITORS
#113Macrocyclic salt-inducible kinase inhibitors
#114IAP binding compounds
#115Macrocyclic purines for the treatment of viral infections
#116Forms of rifaximin and uses thereof
#117Materials for organic electroluminescent devices
#118Macrocyclic LRRK2 kinase inhibitors
#119Compounds for the treatment of hepatitis C
#120Tetracyclic CDK9 kinase inhibitors
#121Rapamycin analogue
#122Methods for the acylation of maytansinol
#123Serine/threonine kinase inhibitors
#124Synthesis of an antiviral compound
#125Crystalline forms of an antiviral compound
#126Use of 7-alkoxy fangchinoline compounds in preventing, alleviating and/or treating depression
#127MACROCYCLIC COMPOUNDS FOR INHIBITION OF INHIBITORS OF APOPTOSIS
#128COMPOUNDS AND METHODS OF TREATING HYPERTENSION
#129Tricyclic heterocycles as bet protein inhibitors
#130Methods and intermediates for preparing macrolactams
#131Rifaximin powder, process for preparing the same an controlled release compositions containing said rifaximin useful for obtaining a long-lasting effect
#132Methods of treating diabetes
#133Macrocyclic LRRK2 kinase inhibitors
#134Crystal forms of a HCV protease inhibitor
#135Macrocyclic heterocyclic compound for inhibiting hepatitis C virus and preparation and use thereof
#136Process and intermediates for preparing macrolactams
#137Methods for the acylation of maytansinol
#138Compounds Useful For Making HCV Protease Inhibitors
#139Inhibitors of human immunodeficiency virus replication
#140Materials for organic electroluminescent devices
#141Inhibitors of hepatitis C virus
#142Forms of rifaximin and uses thereof
#143Cytotoxic agents comprising new ansamitocin derivatives
#144Inhibitors of beta-secretase
#145New Use of Staurosporine Derivatives
#146Process and intermediates for preparing macrolactams
#147Pyrido and pyrimidopyrimidine derivatives as anti-profilerative agents
#148Processes for preparation of Everolimus and intermediates thereof
#149Fused tetracyclic pyrido [4,3-B] indole and pyrido [3,4-B] indole derivatives and methods of use
#150Fused tetracyclic pyrido [4,3-B] indole and pyrido [3,4-B] indole derivatives and methods of use
#151Oxygen linked pyrimidine derivatives
#152Compounds for the treatment of hepatitis C
#153Forms of rifaximin and uses thereof
#154Tricarbonyl technetium-99m, rhenium-185/187, or rhenium-188 labeled cyclic RGD derivatives and uses thereof
#155Bridged triarylamines and -phosphines as materials for electronic devices
#156Rifaximin powder, process for preparing the same and controlled release compositions containing said rifaximin useful for obtaining a long-lasting effect
#157Antibacterial Agent for Drug-Resistant Bacteria, Method for Screening for Same, and Use of Same
#158Oxygen linked pyrimidine derivatives
#159Compounds for the reduction of beta-amyloid production
#160Organic electroluminescence device
#161Heteroalkyl linked pyrimidine derivatives
#162FORMS OF RIFAXIMIN AND USES THEREOF
#163IAP BINDING COMPOUNDS
#164ANTIVIRAL COMPOUNDS
#165Inhibitors of beta-secretase
#166Quinolone analogs and methods related thereto
#167Cytotoxic agents comprising new maytansinoids
#168FORMS OF RIFAXIMIN AND USES THEREOF
#169HYDRAZIDE COMPOUNDS AND USES THEREOF
#170Pyridoindolobenzox—and thiazepine derivatives and uses thereof
#171Azatricyclic antibiotic compounds
#172TUBEROUS SCLEROSIS TREATMENT
#173Antifungal Agents
#174Hydroxylthienoquinolones and related compounds as anti-infective agents
#175Forms of rifaximin and uses thereof
#176Immunophilin Ligands and Methods for Modulating Immunophilin and Calcium Channel Activity
#177Pyrido-and pyrimidopyrimidine derivatives as anti-proliferative agents
#178Organic electroluminescence device
#179GlyT1 receptor antagonists
#180Antiviral compounds
#181Heteroalkyl linked pyrimidine derivatives
#182Quinolone carboxylic acid-substituted rifamycin derivatives
#183Macrocyclic, pyridazinone-containing hepatitis C serine protease inhibitors
#184Quinolone analogs and methods related thereto
#185Oxygen linked pyrimidine derivatives
#186IAP binding compounds
#187Macrocyclic ghrelin receptor modulators and methods of using the same
#1881,5,6,-substituted-2-oxo-3-cyano-1,6a-diaza-tetrahydro-fluoranthenes as anti-inflective agents
#189Pharmaceutical uses of staurosporine derivatives
#190Cytotoxic agents comprising new maytansinoids
#191Cytotoxic agents comprising new maytansinoids
#192Cytotoxic agents comprising new maytansinoids
#193Rifamycin analogs and uses thereof
#194Pyrido-and pyrimidopyrimidine derivatives as anti-profilerative agents
#195IAP binding compounds
#196Tetracyclic azepinoindole compounds
#197Rifamycin analogs and uses thereof
#198Macrocyclic indole derivatives